Volume 29, Issue Supplement_1, February 2023

Adverse Events Related to Therapy

A RARE PRESENTATION OF MYCOPHENOLATE MOFETIL-INDUCED SEGMENTAL COLITIS MASQUERADING AS ISCHEMIC COLITIS

Clive Miranda and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S1, https://doi.org/10.1093/ibd/izac247.001

• Abstract
• View article

ARTHRITIS AND ARTHRALGIA AS EXTRAINTESTINAL MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB: A META-ANALYSIS

Gabriele Alves dos Anjos and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S1–S2, https://doi.org/10.1093/ibd/izac247.002

• Abstract
• View article

SAFETY OF PERIOPERATIVE BIOLOGICS IN PATIENTS WITH IBD UNDERGOING RESECTIVE BOWEL SURGERY: THE MUNICH IBD CENTER EXPERIENCE

Thomas Ochsenkühn and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S2, https://doi.org/10.1093/ibd/izac247.003

• Abstract
• View article

THE UNFORTUNATE PERFECT STORM - SEPTIC SHOCK DUE TO CHRONIC IMMUNOSUPPRESIVE MEDICAL THERAPY AND MEDICATION-INDUCED LYMPHOMA

Benjamin Ravichander and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S2–S3, https://doi.org/10.1093/ibd/izac247.004

• Abstract
• View article

THE USE OF IMMUNOMODULATORS, BIOLOGIC THERAPIES AND SMALL MOLECULES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND SOLID ORGAN TRANSPLANTS

Wissam Ghusn and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S3, https://doi.org/10.1093/ibd/izac247.005

• Abstract
• View article

Animal Models of IBD: Pre-Clinical Treatment of Intestinal Inflammation

A NOVEL GUT-RESTRICTED ARYL HYDROCARBON RECEPTOR AGONIST WITH ACTIVITY IN THE DEXTRAN SODIUM SULFATE COLITIS MURINE MODEL

Matt Davidson and Julie Saiki

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S3, https://doi.org/10.1093/ibd/izac247.006

• Abstract
• View article

A PRECLINICAL MODEL OF STENOTIC CROHN’S DISEASE FOR THE STUDY OF MECHANISMS OF MOTILITY DYSFUNCTION IN IBD

John Johnson and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S3, https://doi.org/10.1093/ibd/izac247.007

• Abstract
• View article

COLON TARGETED DELIVERY AND STABILIZATION OF MONOCLONAL ANTIBODIES FOR LOCAL TREATMENT OF INFLAMMATORY BOWEL DISEASES

Vipul Yadav and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S3–S4, https://doi.org/10.1093/ibd/izac247.008

• Abstract
• View article

DEVELOPMENT OF NANOPARTICLE-ENCAPSULATED BRD4 INHIBITORS FOR NOVEL EPIGENETIC THERAPEUTICS OF IBD

Mansi Shah and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S4, https://doi.org/10.1093/ibd/izac247.009

• Abstract
• View article

HISTOPATHOLOGICAL CHARACTERIZATION OF A CHRONIC DSS-INDUCED MOUSE MODEL OF IBD WITH INTESTINAL FIBROSIS

Malte Hasle Nielsen and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S4, https://doi.org/10.1093/ibd/izac247.010

• Abstract
• View article

LMT503, A NOVEL THERAPY FOR INFLAMMATORY BOWEL DISEASE THROUGH MACROPHAGE POLARIZATIONS BY METABOLIC REPROGRAMMING OF ACTIVATED MACROPHAGE

Wheeseong Lee and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S4–S5, https://doi.org/10.1093/ibd/izac247.011

• Abstract
• View article

LONGITUDINAL COMPRESSION THERAPY FOR SMALL BOWEL STRICTURE CROHN'S DISEASE: DURABLE RESOLUTION IN SWINE MODEL

Juan Verde and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S5, https://doi.org/10.1093/ibd/izac247.012

• Abstract
• View article

NAD⁺ DEPLETION IN THE INTESTINAL EPITHELIUM RESULTS IN MITOCHONDRIAL DYSFUNCTION AND INFLUENCES THE PATHOGENESIS OF EXPERIMENTAL COLITIS

Elizabeth Novak and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S5–S6, https://doi.org/10.1093/ibd/izac247.013

• Abstract
• View article

THE ORAL GLUTMATE CARBOXYPEPTIDASE II INHIBITOR (S)-IBD3540 ROBUSTLY ATTENUATES INFLAMMATION IN SPONTANEOUS IL10 COLITIS

Diane Peters and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S6, https://doi.org/10.1093/ibd/izac247.014

• Abstract
• View article

Comparative Effectiveness Studies

COMPARATIVE EFFECTS OF BIOLOGICS IN PREVENTING PENETRATING COMPLICATIONS IN CROHN’S DISEASE

Parakkal Deepak and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S6–S7, https://doi.org/10.1093/ibd/izac247.015

• Abstract
• View article

EFFICACY AND SAFETY OF VEDOLIZUMAB AND TUMOR NECROSIS FACTOR INHIBITORS IN THE TREATMENT OF STEROID-REFRACTORY MICROSCOPIC COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Nabil El Hage Chehade and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S7, https://doi.org/10.1093/ibd/izac247.016

• Abstract
• View article

MULTIDISCIPLINARY MANAGEMENT, ANTI-TNF THERAPY, AND CLINICAL OUTCOMES OF INTERNALLY PENETRATING CROHN’S DISEASE COMPLICATION IN PEDIATRICS: INTERIM ANALYSES OF A MULTICENTER RETROSPECTIVE COHORT

Brad Constant and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S7–S8, https://doi.org/10.1093/ibd/izac247.017

• Abstract
• View article

Controlled Clinical Trials in Humans

ACCELERATED INFLIXIMAB INFUSION SAFETY AND TOLERABILITY IS NON-INFERIOR TO STANDARD INFUSION PROTOCOL IN INFLAMMATORY BOWEL DISEASE PATIENTS – A RANDOMIZED CONTROLLED STUDY

Suha Abushamma and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S8–S9, https://doi.org/10.1093/ibd/izac247.018

• Abstract
• View article

CURCUMIN-QINGDAI COMBINATION FOR PATIENTS WITH ACTIVE ULCERATIVE COLITIS: A RANDOMIZED DOUBLE-BLINDED PLACEBO-CONTROLLED CLINICAL TRIAL

Shomron Ben-Horin and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S9, https://doi.org/10.1093/ibd/izac247.019

• Abstract
• View article

DEVELOPMENT OF A NOVEL DRUG DELIVERY SYSTEM (DDS) TO DELIVER DRUGS DIRECTLY TO THE COLONIC MUCOSA TO IMPROVE EFFICACY AND REDUCE SYSTEMIC EXPOSURE FOR THE TREATMENT OF ULCERATIVE COLITIS (UC)

Shaoying Nikki Lee and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S9–S10, https://doi.org/10.1093/ibd/izac247.020

• Abstract
• View article

IMPROVEMENT IN BOWEL URGENCY IS ASSOCIATED WITH STOOL FREQUENCY AND RECTAL BLEEDING REMISSION AT 12 AND 52 WEEKS IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS

Millie Long and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S10–S11, https://doi.org/10.1093/ibd/izac247.021

• Abstract
• View article

POTENTIAL EFFECTS OF FOOD ON A NOVEL DRUG DELIVERY SYSTEM (DDS) TO DELIVER A THERAPEUTIC COMPOUND IN THE COLON

Shaoying Nikki Lee and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S11, https://doi.org/10.1093/ibd/izac247.022

• Abstract
• View article

COVID and Clinical Practice

DRUG INTERACTION BETWEEN PAXLOVID AND TACROLIMUS IN AN ADOLESCENT WITH INFLAMMATORY BOWEL DISEASE

Leenoy Zaarur and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S11, https://doi.org/10.1093/ibd/izac247.023

• Abstract
• View article

Cytokines, Signaling and Receptors

A NOVEL BISPECIFIC CD8 TREG MODULATOR TARGETING CYTOLYTIC CD8 REGULATORY T CELLS REDUCES PATHOGENIC CD4 T CELLS AND INFLAMMATION IN TRANSLATIONAL MODELS OF INTESTINAL AUTOIMMUNE AND INFLAMMATORY DISEASE

Jennifer Gardell and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S12, https://doi.org/10.1093/ibd/izac247.024

• Abstract
• View article

Diagnostics in IBD

EVALUATION OF CLINICAL VARIABLES, RADIOLOGICAL VISUAL ANALOG SCORING, AND RADIOMICS FEATURES ON CT ENTEROGRAPHY FOR CHARACTERIZING SEVERE INFLAMMATION AND FIBROSIS IN STRICTURING CROHN’S DISEASE

Joseph Sleiman and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S12–S13, https://doi.org/10.1093/ibd/izac247.025

• Abstract
• View article

MUCOSAL EXPRESSION OF GENES PI3, ANXA1, AND VDR DESCRIMINATES CROHNS DISEASE FROM ULCERATIVE COLITIS IN INFLAMMATORY BOWEL DISEASE PATIENTS

Jaslin James and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S13, https://doi.org/10.1093/ibd/izac247.026

• Abstract
• View article

PERIPHERAL BLOOD EXTRACELLULAR VESICLE LIPIDS AS BIOMARKERS FOR HUMAN INFLAMMATORY BOWEL DISEASE

Syed Adeel Hassan and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S13, https://doi.org/10.1093/ibd/izac247.027

• Abstract
• View article

THE UTILITY OF BIOPSYING ENDOSCOPICALLY NORMAL APPEARING TERMINAL ILEUM

Haily Vora and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S13–S15, https://doi.org/10.1093/ibd/izac247.028

• Abstract
• View article

YIELD OF SERIAL TESTING FOR TUBERCULOSIS EXPOSURE IN THE STUDY OF A PROSPECTIVE ADULT RESEARCH COHORT WITH INFLAMMATORY BOWEL DISEASES (SPARC IBD)

Sean Lapp and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S15, https://doi.org/10.1093/ibd/izac247.029

• Abstract
• View article

Diet and IBD

A DIET AND LIFESTYLE-FACTOR INTERVENTION PROGRAM TO IMPROVE NUTRITIONAL STATUS, SYMPTOMS, AND QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Joseph Rogers and Brittany Rogers

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S15, https://doi.org/10.1093/ibd/izac247.030

• Abstract
• View article

ERGOGENIC AID USE IN ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE AND MEDICAL PROFESSIONAL COMFORTABILITY IN NUTRITIONAL EDUCATION

Caitlin Diefendorf and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S15–S16, https://doi.org/10.1093/ibd/izac247.031

• Abstract
• View article

FEASIBILITY OF A NURSE AND DIETITIAN-LED IBD SURGICAL PREHABILITATION PROGRAM

Andrea Banty and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S16, https://doi.org/10.1093/ibd/izac247.032

• Abstract
• View article

FOOD ACCESS AND MENTAL HEALTH IN PEDIATRIC INFLAMMATORY BOWEL DISEASE

Nicole Zeky and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S16, https://doi.org/10.1093/ibd/izac247.033

• Abstract
• View article

WHICH IS IMPORTANT? GLUTEN FREE DIET OR INFLAMMATORY BOWEL DISEASE MEDICATIONS IN SUBJECTS WITH AN OVERLAP WITH CELIAC DISEASE AND INFLAMMATORY BOWEL DISEASE: OBSERVATIONS FROM A CASE SERIES AT A LARGE ACADEMIC CENTER

Jonathan Montrose and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S16–S17, https://doi.org/10.1093/ibd/izac247.034

• Abstract
• View article

Disease Activity Assessment

AN OBSERVATIONAL STUDY DEMONSTARTING THE MEASUREMENT, CHARACTERIZATION AND VALIDATION OF EXPRESSIONS OF CALPROTECTIN IN HUMAN SWEAT THROUGH A SWEAT WEARABLE

Shalini Prasad and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S17–S18, https://doi.org/10.1093/ibd/izac247.035

• Abstract
• View article

ENDOSCOPIC SCORE INTER-READER CONCORDANCE ANALYSIS FROM A PHASE 2B STUDY IN PATIENTS WITH MILD-TO-MODERATE UC

Brian Feagan and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S18–S19, https://doi.org/10.1093/ibd/izac247.036

• Abstract
• View article

LONGITUDINAL MONITORING OF INFLAMMATORY BOWEL DISEASE ACTIVITY USING WEARABLE DEVICES THROUGH INFLAMMATORY MARKERS IN SWEAT

Robert Hirten and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S19, https://doi.org/10.1093/ibd/izac247.037

• Abstract
• View article

MACHINE LEARNING-BASED PREDICTION OF GEBOES SCORE AND HISTOLOGIC IMPROVEMENT AND REMISSION THRESHOLDS IN ULCERATIVE COLITIS

Zahil Shanis and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S19–S20, https://doi.org/10.1093/ibd/izac247.038

• Abstract
• View article

METHODS TO DERIVE A CROHN'S DISEASE ACTIVITY INDEX FROM ELECTRONIC HEALTH RECORDS DATA

Anna Swenson and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S20–S21, https://doi.org/10.1093/ibd/izac247.039

• Abstract
• View article

METHODS TO DERIVE A MODIFIED MAYO SCORE FROM ELECTRONIC HEALTH RECORDS DATA

Anna Swenson and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S21, https://doi.org/10.1093/ibd/izac247.040

• Abstract
• View article

PHYSIOLOGICAL METRICS COLLECTED FROM WEARABLE DEVICES IDENTIFY INFLAMMATORY AND CLINICAL INFLAMMATORY BOWEL DISEASE FLARES

Robert Hirten and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S21–S22, https://doi.org/10.1093/ibd/izac247.041

• Abstract
• View article

QUANTITATIVE AND EXPLAINABLE ARTIFICIAL INTELLIGENCE (AI)-POWERED APPROACHES TO PREDICT ULCERATIVE COLITIS DISEASE ACTIVITY FROM HEMATOXYLIN AND EOSIN (H&E)-STAINED WHOLE SLIDE IMAGES (WSI)

Kathleen Sucipto and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S22–S23, https://doi.org/10.1093/ibd/izac247.042

• Abstract
• View article

USING R TO ADVANCE PATIENT-CENTRIC RESEARCH IN THE STUDY OF A PROSPECTIVE ADULT RESEARCH COHORT

Tara Fehlmann and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S23, https://doi.org/10.1093/ibd/izac247.043

• Abstract
• View article

Disease Complications

AN UNUSUAL MANIFESTATION OF METASTATIC CROHN’S DISEASE: A CASE REPORT

Narges Ashrafinia and Tomasz Guzowski

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S23, https://doi.org/10.1093/ibd/izac247.044

• Abstract
• View article

ILEOSTOMY AND RISK OF ACUTE KIDNEY INJURY IN PATIENTS WITH CROHN'S DISEASE

Ahmed Abomhya and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S23–S24, https://doi.org/10.1093/ibd/izac247.045

• Abstract
• View article

INCIDENTAL DYSPLASIA DURING TOTAL PROCTOCOLECTOMY WITH ILEOANAL POUCH: IS IT ASSOCIATED WITH WORSE OUTCOMES?

Marianna Maspero and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S24, https://doi.org/10.1093/ibd/izac247.046

• Abstract
• View article

INCORPORATION OF RISK ASSESSMENT TOOL IMPACTS PATIENT AND GASTROENTEROLOGIST CONFIDENCE AND TREATMENT DECISION MAKING IN BIONAIVE CROHN’S DISEASE

Ryan Ungaro and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S24–S25, https://doi.org/10.1093/ibd/izac247.047

• Abstract
• View article

INFLAMMATORY BOWEL DISEASE AND ASSOCIATED CARDIOVASCULAR DISEASE OUTCOMES: A SYSTEMATIC REVIEW

Sidra Naz and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S25, https://doi.org/10.1093/ibd/izac247.048

• Abstract
• View article

LONG RECTAL CUFF SYNDROME AFTER ILEOANAL POUCH FOR INFLAMMATORY BOWEL DISEASE

Marianna Maspero and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S25–S26, https://doi.org/10.1093/ibd/izac247.049

• Abstract
• View article

MOOD DISORDERS AND OUTCOMES OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A 2016-2019 NATIONWIDE ANALYSIS

Yassine Kilani and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S26–S27, https://doi.org/10.1093/ibd/izac247.050

• Abstract
• View article

MORTALITY AND MORBIDITY DIFFERENCE IN GERIATRICS PATIENTS HOSPITALIZED FOR INFLAMMATORY BOWEL DISEASE: POPULATION-BASED AGE-STRATIFIED RETROSPECTIVE STUDY

Mohammad Aldiabat and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S27–S28, https://doi.org/10.1093/ibd/izac247.051

• Abstract
• View article

OUTCOMES OF PEPTIC ULCER DISEASE IN PATIENTS WITH CROHN’S DISEASE: A FOUR YEAR NATIONWIDE ANALYSIS

Yassine Kilani and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S28–S29, https://doi.org/10.1093/ibd/izac247.052

• Abstract
• View article

PENTOSAN POLYSULFATE-ASSOCIATED DYSPLASIA IN INFLAMMATORY BOWEL DISEASE: A CASE SERIES

Jenna Anderson and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S29, https://doi.org/10.1093/ibd/izac247.053

• Abstract
• View article

PREDICTORS OF DEVELOPING MULTIPLE EXTRA-INTESTINAL MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE

Madeline Alizadeh and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S29, https://doi.org/10.1093/ibd/izac247.054

• Abstract
• View article

PRIMARY SCLEROSING CHOLANGITIS AND AUTOIMMUNE HEPATITIS: OVERLAPPING CHALLENGES IN DIAGNOSIS AND TREATMENT

Hannah Fiske and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S29–S30, https://doi.org/10.1093/ibd/izac247.055

• Abstract
• View article

SEPSIS IN THE SETTINGS OF INFLAMMATORY BOWEL DISEASE: STUDYING THE OUTCOMES OF OVER EIGHT-MILLION PATIENTS

Mohammad Aldiabat and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S30–S31, https://doi.org/10.1093/ibd/izac247.056

• Abstract
• View article

SMOKING IS NOT AN INDEPENDENT RISK FACTOR FOR SURGERY IN PATIENTS WITH CROHN'S DISEASE ON BIOLOGIC THERAPY

Manar Shmais and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S31, https://doi.org/10.1093/ibd/izac247.057

• Abstract
• View article

THE IMPACT OF INFLAMMATORY BOWEL DISEASES ON THE OUTCOMES OF PATIENTS ADMITTED WITH ACUTE VIRAL HEPATITIS: A 2016-2019 NATIONWIDE ANALYSIS

Yassine Kilani and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S31–S32, https://doi.org/10.1093/ibd/izac247.058

• Abstract
• View article

THIRD TIME’S THE CHARM? INDICATIONS AND LONG-TERM OUTCOMES AFTER REDO-REDO ILEAL POUCH ANAL ANASTOMOSIS

Marianna Maspero and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S32–S33, https://doi.org/10.1093/ibd/izac247.059

• Abstract
• View article

Epidemiology

AMINOSALICYLATE USE IN PEDIATRIC PATIENTS WITH CROHN’S DISEASE

Perseus Patel and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S33, https://doi.org/10.1093/ibd/izac247.060

• Abstract
• View article

ASSOCIATION BETWEEN ANTIBIOTIC USE AND INFLAMMATORY BOWEL DISEASE OUTCOMES

Luke Liu and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S33–S34, https://doi.org/10.1093/ibd/izac247.061

• Abstract
• View article

ASSOCIATION OF CYCLING BETWEEN ANTI-TNFS VERSUS SWITCHING TO USTEKINUMAB WITH MEDICATION PERSISTENCE IN ANTI-TNF EXPERIENCED PATIENTS WITH CROHN'S DISEASE

Maryia Zhdanava and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S34, https://doi.org/10.1093/ibd/izac247.062

• Abstract
• View article

CHARACTERIZING THE JOHNS HOPKINS INFLAMMATORY BOWEL DISEASE COHORT USING OMOP CDM

Leonard Haas and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S34–S35, https://doi.org/10.1093/ibd/izac247.063

• Abstract
• View article

HOSPITALIZATION TRENDS IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH POUCHITIS: A POPULATION-BASED STUDY

Ahmad Nawaz and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S35, https://doi.org/10.1093/ibd/izac247.064

• Abstract
• View article

IBD AND RHEUMATOLOGICAL DISEASE OVERLAP IN A PREDOMINATELY AFRICAN AMERICAN CLINIC POPULATION AS COMPARED TO A NATIONAL INPATIENT DATABASE

Mohamad Khaled Almujarkesh and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S35–S36, https://doi.org/10.1093/ibd/izac247.065

• Abstract
• View article

PERSISTENCE WHILE ON LABELED MAINTENANCE DOSE AMONG BIO-EXPERIENCED PATIENTS WITH CROHN'S DISEASE INITIATED ON USTEKINUMAB COMPARED TO ADALIMUMAB

Maryia Zhdanava and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S36, https://doi.org/10.1093/ibd/izac247.066

• Abstract
• View article

REAL-WORLD USTEKINUMAB PERSISTENCE IN PATIENTS WITH ULCERATIVE COLITIS ATTAINING THE MAINTENANCE PHASE

Maryia Zhdanava and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S36–S37, https://doi.org/10.1093/ibd/izac247.067

• Abstract
• View article

SUPERIOR PERSISTENCE WHILE ON LABELED MAINTENANCE DOSE AMONG BIO-NAÏVE PATIENTS WITH CROHN'S DISEASE INITIATED ON USTEKINUMAB COMPARED TO ADALIMUMAB

Maryia Zhdanava and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S37, https://doi.org/10.1093/ibd/izac247.068

• Abstract
• View article

TREATMENT PATTERNS OF PEDIATRIC AND ADULT PATIENTS WITH CROHN’S DISEASE

Wai Man Chan and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S37–S38, https://doi.org/10.1093/ibd/izac247.069

• Abstract
• View article

TREATMENT PATTERNS OF PEDIATRIC AND ADULT PATIENTS WITH ULCERATIVE COLITIS

Wai Man Chan and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S38–S39, https://doi.org/10.1093/ibd/izac247.070

• Abstract
• View article

Genomics and Gene Function

ANALYSIS OF THE GENETIC EXPRESSION OF COLON CANCER GENETIC BIOMARKERS ON INFLAMMATORY BOWEL DISEASE ON BLOOD AND BIOPSY SAMPLES

Evelyn Calderon Martinez and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S39, https://doi.org/10.1093/ibd/izac247.071

• Abstract
• View article

ASSESSMENT OF THE IMMUNE CELL LANDSCAPE IN INFLAMMATORY BOWEL DISEASE

Evelyn Calderon Martinez and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S39–S40, https://doi.org/10.1093/ibd/izac247.072

• Abstract
• View article

WHOLE EXOME SEQUENCING OF A MULTIPLEX CROHN’S DISEASE FAMILY IDENTIFIES RARE ALTERATIONS IN PYGB ANDXRN2 AS POTENTIALLY HIGH IMPACT RISK VARIANTS OF DISEASE

Lea Ann Chen and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S40, https://doi.org/10.1093/ibd/izac247.073

• Abstract
• View article

Health Care Delivery and Policy (Practice Management Including Telehealth, COVID-related Issues, Reimbursement, Access to Care)

A NURSE LED INTERVENTION TO IMPROVE ACCESS TO CARE USING A TELEPHONE TRIAGE ALGORITHM

Andrea Banty and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S40–S41, https://doi.org/10.1093/ibd/izac247.074

• Abstract
• View article

DEMOCRATIC DELIBERATION TO ASSESS VETERAN PREFERENCES FOR BIOSIMILAR MEDICATION SWITCHING FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE IN A RESOURCE CONSCIOUS SETTING

Kerry Ryan and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S41, https://doi.org/10.1093/ibd/izac247.075

• Abstract
• View article

REAL WORLD IMPLEMENTATION OF TREAT-TO-TARGET IN PATIENTS WITH IBD IN A LEARNING HEALTH SYSTEM: AN IBD QORUS COLLABORATIVE STUDY

Siddharth Singh and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S41–S42, https://doi.org/10.1093/ibd/izac247.076

• Abstract
• View article

Health Disparities in Patients with GI Disease

DELAYED ONSET OF TREATMENT IN A PATIENT WITH ULCERATIVE COLITIS: A CASE OF HOW DISPARITIES AFFECT HEALTHCARE ACCESS

Maria Ibarra and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S42–S43, https://doi.org/10.1093/ibd/izac247.077

• Abstract
• View article

DO PROVIDERS FAIL TO RECOGNIZE ANXIETY IN SOCIALLY VULNERABLE PATIENTS WITH INFLAMMATORY BOWEL DISEASE?

Jessica Sheehan and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S43, https://doi.org/10.1093/ibd/izac247.078

• Abstract
• View article

FUNCTIONAL DISABILITY INVENTORY AND ASSOCIATIONS WITH RACE, ETHNICITY, INCOME AND FOOD INSECURITY

Nicole Zeky and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S43, https://doi.org/10.1093/ibd/izac247.079

• Abstract
• View article

INVESTIGATING THE USE OF THE SOCIAL VULNERABILITY INDEX TO PREDICT HEALTHCARE UTILIZATION AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Nhu Dang and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S43–S44, https://doi.org/10.1093/ibd/izac247.080

• Abstract
• View article

MULTIPLE ENVIRONMENTAL AND SOCIAL DETERMINANTS OF HEALTH FACTORS WERE NOT ASSOCIATED WITH THE GASTROINTESTINAL SYMPTOMATIC BURDEN OF ULCERATIVE COLITIS WITH MUCOSAL HEALING

Chung Sang Tse and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S44–S45, https://doi.org/10.1093/ibd/izac247.081

• Abstract
• View article

SOCIALLY VULNERABLE PATIENTS WITH INFLAMMATORY BOWEL DISEASE ARE AT INCREASED RISK FOR VACCINE PREVENTABLE ILLNESS

Ariel Jordan and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S45, https://doi.org/10.1093/ibd/izac247.082

• Abstract
• View article

Immune Host Defenses

THE EFFECTS OF BIOLOGIC AND SMALL MOLECULE INHIBITOR THERAPY ON THE MUCOSAL IMMUNE SYSTEM IN ULCERATIVE COLITIS

Kristi Briggs and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S45–S46, https://doi.org/10.1093/ibd/izac247.083

• Abstract
• View article

Intestinal Inflammation, Fibrosis and Regeneration

A NEW MODEL TO STUDY INTESTINAL FIBROSIS USING IPSC-DERIVED HUMAN EPITHELIAL AND MESENCHYMAL CELLS FROM CROHN’S DISEASE PATIENTS

Christian Wong Valencia and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S46, https://doi.org/10.1093/ibd/izac247.084

• Abstract
• View article

ACONITATE DECARBOXYLASE 1 IS A KEY REGULATOR OF COLITIS

Kara McNamara and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S46, https://doi.org/10.1093/ibd/izac247.085

• Abstract
• View article

COLITIS-ASSOCIATED COLON CANCER: EXPLORING THE DCLK1-S-MMP13-P53 AXIS

Kafayat Yusuf and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S46, https://doi.org/10.1093/ibd/izac247.086

• Abstract
• View article

CREATINE KINASE EXPRESSION IS PROTECTIVE IN A MOUSE COLITIS MODEL

Caroline Hall and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S46–S47, https://doi.org/10.1093/ibd/izac247.087

• Abstract
• View article

EPITHELIAL CELLS OF ULCERATIVE COLITIS PATIENTS REQUIRE NORMAL LEVELS OF MITOCHONDRIA AND BETA-CATENIN TO UTILIZE BUTYRATE METABOLISM AND PROMOTE ULCER HEALING

Iyabo Erinkitola and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S47, https://doi.org/10.1093/ibd/izac247.088

• Abstract
• View article

EXCESS DIETARY SUGAR ALTERS COLONOCYTE METABOLISM AND IMPAIRS THE EARLY PROLIFERATIVE RESPONSE TO DAMAGE

Ansen Burr and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S47, https://doi.org/10.1093/ibd/izac247.089

• Abstract
• View article

METABOLOMICS ANALYSIS IDENTIFIED AN ORALLY ACTIVE METABOLITE FOR TREATING CROHN’S DISEASE-ASSOCIATED INTESTINAL FIBROSIS

Hon Wai Koon

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S47–S48, https://doi.org/10.1093/ibd/izac247.090

• Abstract
• View article

PROBIOTIC BIFIDOBACTERIUM AND A NEW GENERATION POSTBIOTIC: ALGINIC ACID

Hüseyin Bozkurt

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S48, https://doi.org/10.1093/ibd/izac247.091

• Abstract
• View article

SELECTION OF DIETARY FIBERS FOR GUT HEALTH BASED ON THEIR PHYSICOCHEMICAL PROPERTIES

Edward Moncada and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S48, https://doi.org/10.1093/ibd/izac247.092

• Abstract
• View article

STRUCTURAL MODIFICATIONS OF BUTYRATE REVEAL TEMPLATES FOR INTESTINAL EPITHELIAL HIF STABILIZERS

Alfredo Ornelas and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S48–S49, https://doi.org/10.1093/ibd/izac247.093

• Abstract
• View article

Microbiome Role in Intestinal Inflammation

AUPHOS, A NOVEL DRUG THAT IMPROVES COLITIS BY MICROBIOME INDUCED METABOLIC CHANGES

James Warinner and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S49, https://doi.org/10.1093/ibd/izac247.094

• Abstract
• View article

BUTYRATE AMELIORATES PANETH CELL DEFECTS, TOTAL INFLAMMATION, AND EPITHELIAL CELL APOPTOSIS DURING MITOCHONDRIAL DYSFUNCTION DRIVEN BY PROHIBITIN 1-DEFICIENCY

Kibrom Alula and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S49, https://doi.org/10.1093/ibd/izac247.095

• Abstract
• View article

COMMENSAL GUT BACTERIA REGULATE HIF ACTIVITY TO PROMOTE INTESTINAL HOMEOSTASIS

Alexander Dowdell and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S49, https://doi.org/10.1093/ibd/izac247.096

• Abstract
• View article

DIFFERENTIAL ABUNDANCE OF THE FUNGAL MYCOBIOME IN PATIENTS WITH ULCERATIVE COLITIS

Katie Hsia and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S49–S50, https://doi.org/10.1093/ibd/izac247.097

• Abstract
• View article

THE ONSET AND SEVERITY OF ULCERATIVE COLITIS IN IL-10 -/- MICE IS NOT DEPENDENT ON FECAL MICROBIOTA TRANSPLANTATION FROM ULCERATIVE COLITIS PATIENTS

Kayla Roy and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S50, https://doi.org/10.1093/ibd/izac247.098

• Abstract
• View article

Mucosal Innate Function and Innate Host Defense: Inflammatory Bowel Disease

INNATE TL1A SIGNALING PROMOTES INTESTINAL NEUTROPHIL ACTIVATION AND COLITIS ASSOCIATED CANCER

Silvia Pires and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S50, https://doi.org/10.1093/ibd/izac247.099

• Abstract
• View article

IRE1α-XBP1 CONTROLS GROUP 3 INNATE LYMPHOID CELLS IN INFLAMMATORY BOWEL DISEASE

Siyan Cao and Marco Colonna

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S50–S51, https://doi.org/10.1093/ibd/izac247.100

• Abstract
• View article

REPOGRAMING OF THE INTESTINAL IMMUNE CELL COMPARTMENT DEFINES THE RESPONSE TO AUTOLOGOUS STEM CELL TRANSPLANTATION IN CROHNS DISEASE

Daniela Guisado and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S51–S52, https://doi.org/10.1093/ibd/izac247.101

• Abstract
• View article

SINGLE CELL RNA SEQUENCING OF ULCERATIVE COLITIS AND CROHN'S DISEASE TISSUE SAMPLES INFORMS THE SELECTION OF TREM1 AS A TARGET FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES

Sarah Grant and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S52–S53, https://doi.org/10.1093/ibd/izac247.102

• Abstract
• View article

Natural History, Environmental Exposures, and Outcomes

EFFECTS OF ACTIVE PATIENT PARTICIPATION IN AN INFLAMMATORY BOWEL DISEASE QUALITY IMPROVEMENT PROGRAM ON HEALTHCARE UTILIZATION OUTCOMES

Nhu Dang and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S53, https://doi.org/10.1093/ibd/izac247.103

• Abstract
• View article

NEW ONSET OF INFLAMMATORY BOWEL DISEASE IN A PATIENT WITH EOSINOPHILIC ESOPHAGITIS: 10-YEAR CONSTELLATION OF AUTOIMMUNE GASTROINTESTINAL DISORDERS

Adalberto Guzman and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S53–S54, https://doi.org/10.1093/ibd/izac247.104

• Abstract
• View article

REAL-WORLD EXPERIENCE FOR BIOLOGIC USE IN IBD IN THAI: A SINGLE-CENTER EXPERIENCE

Julajak Limsrivilai and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S54–S55, https://doi.org/10.1093/ibd/izac247.105

• Abstract
• View article

Non-Immune Cells in Intestinal Inflammation: Epithelium and Stroma

A NOVEL DRUG THERAPY INDUCES MITOCHONDRIAL BIOGENESIS AND ATTENUATES COLITIS

Sarayu Bhogoju and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S55, https://doi.org/10.1093/ibd/izac247.106

• Abstract
• View article

TRANSFER RNA MODIFICATION CONTRIBUTE TO PATHOGENESIS OF INTESTINAL INFLAMMATION BY ALTERING EPITHELIAL BARRIERS

Jilei Zhang and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S55–S56, https://doi.org/10.1093/ibd/izac247.107

• Abstract
• View article

Omics for Prognosis, Therapeutic Selection, and Mechanisms

BULK RNA-SEQUENCING OF BLOOD INFORMS MOLECULAR DIAGNOSES IN VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE

Lauren Collen and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S56, https://doi.org/10.1093/ibd/izac247.108

• Abstract
• View article

DEVELOPMENT OF AN OPTIMAL MACHINE LEARNING MODEL USING TREATMENT NAÏVE DIAGNOSTIC PATHOLOGY IMAGES TO PREDICT STEROID-FREE CLINICAL REMISSION AT ONE YEAR IN PEDIATRIC ULCERATIVE COLITIS

Jasbir Dhaliwal and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S56–S57, https://doi.org/10.1093/ibd/izac247.109

• Abstract
• View article

GUT MICROBIAL METABOLISM OF 5-ASA IS PROSPECTIVELY ASSOCIATED WITH TREATMENT FAILURE IN PATIENTS WITH IBD

Raaj Mehta and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S57–S58, https://doi.org/10.1093/ibd/izac247.110

• Abstract
• View article

HLA-DQA1*05 ASSOCIATES WITH IMMUNOGENICITY AND LOSS OF RESPONSE TO ANTI-TNF THERAPY IN THE IBD POPULATION: A META-ANALYSIS

Suzannah Bergstein and Elizabeth Spencer

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S58, https://doi.org/10.1093/ibd/izac247.111

• Abstract
• View article

MUCOSAL IMMUNE SIGNATURES OF PERIANAL FISTULIZING CROHN’S DISEASE BY MASS CYTOMETRY

Siyan Cao and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S58–S59, https://doi.org/10.1093/ibd/izac247.112

• Abstract
• View article

PRO-INFLAMMATORY SIRPα-EXPRESSING MONOCYTES AND MACROPHAGES MEDIATE ANTI-TNF REFRACTORY CROHN'S DISEASE IN CHILDREN

Duke Geem and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S59–S60, https://doi.org/10.1093/ibd/izac247.113

• Abstract
• View article

THE PRECIOUS STUDY: A PROSPECTIVE, OBSERVATIONAL STUDY OF CD8+ BIOMARKER BASED PROGNOSTIC TEST IN NORTH AMERICAN IBD PATIENTS

Lea Ann Chen and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S60, https://doi.org/10.1093/ibd/izac247.114

• Abstract
• View article

Pediatric IBD: Clinical and Translational Studies

ERYTHEMA NODOSUM AND PYODERMA GANGRENOSUM IN PEDIATRIC INFLAMMATORY BOWEL DISEASE

Miranda Yousif and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S60–S61, https://doi.org/10.1093/ibd/izac247.115

• Abstract
• View article

GROWTH OUTCOMES OF IV ANTI-TNF BIOSIMILARS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE

Madeline McClinchie and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S61–S62, https://doi.org/10.1093/ibd/izac247.116

• Abstract
• View article

NON-MEDICAL SWITCHING FROM INFLIXIMAB TO A BIOSIMILAR IN ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE

Megan McNicol and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S62, https://doi.org/10.1093/ibd/izac247.117

• Abstract
• View article

SINGLE CENTER EXPERIENCE WITH UPADACITINIB FOR REFRACTORY PEDIATRIC INFLAMMATORY BOWEL DISEASE

Suzannah Bergstein and Elizabeth Spencer

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S62, https://doi.org/10.1093/ibd/izac247.118

• Abstract
• View article

SPATIAL CONCORDANCE OF LEFT AND RIGHT COLON FINDINGS IN PEDIATRIC PATIENTS WITH ULCERATIVE COLITIS AFTER TREAMTENT

Meenal Thadasina and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S62–S63, https://doi.org/10.1093/ibd/izac247.119

• Abstract
• View article

Practice Management, Quality of Care, Quality Assurance

AN ASSESSMENT OF HEALTHCARE PROFESSIONAL KNOWLEDGE REGARDING INVESTIGATIONAL STEM CELL THERAPIES FOR PATIENTS WITH CROHN’S PERIANAL FISTULA: A US MULTISPECIALITY EDUCATIONAL NEEDS SURVEY

Greg Salinas and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S63, https://doi.org/10.1093/ibd/izac247.120

• Abstract
• View article

EFFICACY AND SAFETY OF HYPERBARIC OXYGEN THERAPY IN FISTULIZING CROHN'S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS

Amr Dokmak and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S63, https://doi.org/10.1093/ibd/izac247.121

• Abstract
• View article

ENGAGING PATIENTS IN INFLAMMATORY BOWEL DISEASE CARE — WHAT DETERMINES ACTIVE PARTICIPATION?

Nhu Dang and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S63–S65, https://doi.org/10.1093/ibd/izac247.122

• Abstract
• View article

IMPACT OF NON ST- ELEVATION MYOCARDIAL INFARCTION (NSTEMI) ON PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Herman Suga and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S65, https://doi.org/10.1093/ibd/izac247.123

• Abstract
• View article

MANAGEMENT STRATEGIES FOR OBESITY VARY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Sonya Dave and Poonam Beniwal-Patel

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S65–S66, https://doi.org/10.1093/ibd/izac247.124

• Abstract
• View article

TREATMENT PREFERENCES IN CROHN’S DISEASE PERIANAL FISTULA: PERSPECTIVES OF HEALTHCARE PROFESSIONALS

Jeanne Jiang and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S66–S67, https://doi.org/10.1093/ibd/izac247.125

• Abstract
• View article

USING A REAL TIME DASHBOARD TO SUPPORT POPULATION HEALTH IN INFLAMMATORY BOWEL DISEASE

Robert Lloyd and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S67, https://doi.org/10.1093/ibd/izac247.126

• Abstract
• View article

Quality of Life and Psychosocial Care

DEFINING LONG-TERM QUALITY OF LIFE AND FUNCTIONAL OUTCOMES AFTER REDO ILEAL POUCH ANAL ANASTOMOSIS: WHAT SHOULD PATIENTS AND PROVIDERS EXPECT?

Marianna Maspero and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S67, https://doi.org/10.1093/ibd/izac247.127

• Abstract
• View article

EXPLORING RELATEDNESS AS SOUGHT BY ADOLESCENTS AND YOUNG ADULTS IN AN ONLINE INSTAGRAM INFLAMMATORY BOWEL DISEASE SUPPORT COMMUNITY

Caeli Malloy and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S67–S68, https://doi.org/10.1093/ibd/izac247.128

• Abstract
• View article

PATIENT PERSPECTIVE OF BOWEL URGENCY AND BOWEL URGENCY-RELATED ACCIDENTS IN CROHN’S DISEASE

Vipul Jairath and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S68, https://doi.org/10.1093/ibd/izac247.129

• Abstract
• View article

PATIENT PERSPECTIVES OF BOWEL URGENCY AND BOWEL URGENCY-RELATED ACCIDENTS IN ULCERATIVE COLITIS

Vipul Jairath and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S68–S69, https://doi.org/10.1093/ibd/izac247.130

• Abstract
• View article

PRELIMINARY EVIDENCE FOR A RELATIONSHIP BETWEEN HEART RATE VARIABILITY AND FATIGUE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)

Josie McGarva and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S69, https://doi.org/10.1093/ibd/izac247.131

• Abstract
• View article

THE INTERPLAY OF IBD AND DEPRESSION IN INPATIENT LENGTH OF STAY, COST, AND COMPLICATIONS

Rachel Dong and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S69–S70, https://doi.org/10.1093/ibd/izac247.132

• Abstract
• View article

THE RELATIONSHIP BETWEEN SELF-REPORTED SLEEP, WRIST ACTIGRAPHY, AND SYMPTOMS AMONG ADULTS WITH INFLAMMATORY BOWEL DISEASE (IBD)

Samantha Winders and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S70, https://doi.org/10.1093/ibd/izac247.133

• Abstract
• View article

TRENDS AND RELATED FACTORS OF QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Sihyun Kim and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S70–S71, https://doi.org/10.1093/ibd/izac247.134

• Abstract
• View article

Role of the Gut Microbiome and Pathogens in Immune and Inflammatory Diseases

BUTYRATE-INDUCED MITOCHONDRIAL FUNCTION IMPROVES BARRIER FUNCTION IN INFLAMMATORY BOWEL DISEASE (IBD)

Evan Conder and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S71–S72, https://doi.org/10.1093/ibd/izac247.135

• Abstract
• View article

LOSS OF EPITHELIAL DUOX2 SIGNALING IS ACCOMPANIED BY A REDUCTION IN AKKERMANSIACEAE AND PROMOTES THE DEVELOPMENT OF METABOLIC SYNDROME IN A MICROBIOME-DEPENDENT MANNER

Hajar Hazime and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S72, https://doi.org/10.1093/ibd/izac247.136

• Abstract
• View article

PATHOPHYSIOLOGY OF IRRITABLE BOWEL SYNDROME IN PATIENTS WITH QUIESCENT INFLAMMATORY BOWEL DISEASE

Diego Brandão Oliveira and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S72, https://doi.org/10.1093/ibd/izac247.137

• Abstract
• View article

THE BENEFICIAL ROLE OF PROBIOTIC AKKERMANSIA MUCINIPHILA IN INFLAMMATORY BOWEL DISEASE

Mengyu Zheng and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S72, https://doi.org/10.1093/ibd/izac247.138

• Abstract
• View article

THE GUT MICROBIOME REGULATES EFFICACY OF SULFASALAZINE THERAPY FOR SPONDYLOARTHRITIS IN INFLAMMATORY BOWEL DISEASE

Svetlana Lima and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S72–S73, https://doi.org/10.1093/ibd/izac247.139

• Abstract
• View article

Special Populations, Conception, Adolescent, and Older

ESRD IN PATIENTS WITH IBD: AN ANALYSIS OF THE NATIONAL INPATIENT SAMPLE 2015-2019

Christopher Chhoun and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S73, https://doi.org/10.1093/ibd/izac247.140

• Abstract
• View article

INTESTINAL PERFORATIONS IN PATIENTS WITH IBD: AN ANALYSIS OF THE NATIONAL INPATIENT SAMPLE 2015-2019

Christopher Chhoun and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S73, https://doi.org/10.1093/ibd/izac247.141

• Abstract
• View article

THE PRESENCE OF CARDIAC ARRHYTHMIAS IS ASSOCIATED WITH INCREASED MORTALITY IN HOSPITALIZED PATIENTS WHO ARE UNDERGOING ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) WITH A CONCURRENT DIAGNOSIS OF IBD

Herman Suga and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S73–S74, https://doi.org/10.1093/ibd/izac247.142

• Abstract
• View article

Therapeutic Monitoring

DEVELOPMENT AND VALIDATION OF A PATIENT-REPORTED OUTCOME MEASURE FOR CROHN’S DISEASE: THE CROHN’S DISEASE-HEALTH INDEX (CD-HI), A FULLY VALIDATED TOOL TO BOLSTER CLINICAL TRIAL AND RESEARCH INFRASTRUCTURE

Spencer Rosero and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S74–S75, https://doi.org/10.1093/ibd/izac247.143

• Abstract
• View article

PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF AMISELIMOD, A SELECTIVE SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 STUDY

Jimin Lee and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S75, https://doi.org/10.1093/ibd/izac247.144

• Abstract
• View article

SEX-BASED DIFFERENCES IN DRUG DURABILITY AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Ankita Tirath and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S75–S76, https://doi.org/10.1093/ibd/izac247.145

• Abstract
• View article

SUBCUTANEOUS INFLIXIMAB IN REFRACTORY CROHN'S DISEASE PATIENTS AFTER THE MULTIPLE TREATMENT FAILURES - SHORT TREATMENT OUTCOMES

Milan Lukas and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S76, https://doi.org/10.1093/ibd/izac247.146

• Abstract
• View article

Translational Application of Intestinal Stem Cells and Organoid Models

EICOSATETRAYNOIC ACID REGULATES PRO-FIBROTIC PATHWAYS IN AN INDUCED PLURIPOTENT STEM CELL DERIVED MACROPHAGE:HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN’S DISEASE

Benjamin Dreskin and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S76–S77, https://doi.org/10.1093/ibd/izac247.147

• Abstract
• View article

ESTABLISHMENT AND TREATMENT OF MURINE COLONOIDS TO STUDY THE EPITHELIAL EFFECTS OF INTESTINAL INFLAMMATION IN VITRO

Erin Crawford and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S77, https://doi.org/10.1093/ibd/izac247.148

• Abstract
• View article

Uncontrolled Therapeutic Observations in Humans Biologic

A PHASE II OPEN LABEL STUDY OF NEIHULIZUMAB, AN ANTI-CD162 (PSGL-1) ANTIBODY, IN PATIENTS WITH MODERATE TO SEVERE ACTIVE, ANTI-TNFα AND/OR ANTI-INTEGRIN REFRACTORY ULCERATIVE COLITIS

David Rubin and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S77–S78, https://doi.org/10.1093/ibd/izac247.149

• Abstract
• View article

EFFICIENCY OF DUAL THERAPY WITH VEDOLIZUMAB AND TOFACITINIB IN REFRACTORY ULCERATIVE COLITIS PATIENTS – SINGLE CENTRE EXPERIENCE

Martin Kolar and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S78, https://doi.org/10.1093/ibd/izac247.150

• Abstract
• View article